The antagonists in the drug policy field, Alfred Lindesmith and Nils Bejerot, made completely different conclusions in the past. Could they have agreed today? Robert L. DuPont, MD, director of the Institute for Behavior and Health, Inc. and the first director of National Institute on Drug Abuse, NIDA, USA, presents an analysis.